197 related articles for article (PubMed ID: 34172890)
1. Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma.
Murakami K; Kanto A; Sakai K; Miyagawa C; Takaya H; Nakai H; Kotani Y; Nishio K; Matsumura N
Mod Pathol; 2021 Nov; 34(11):2071-2079. PubMed ID: 34172890
[TBL] [Abstract][Full Text] [Related]
2. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis.
Suda K; Cruz Diaz LA; Yoshihara K; Nakaoka H; Yachida N; Motoyama T; Inoue I; Enomoto T
Cancer Sci; 2020 Aug; 111(8):3000-3009. PubMed ID: 32473611
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
4. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
5. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
[TBL] [Abstract][Full Text] [Related]
6. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
[TBL] [Abstract][Full Text] [Related]
7. Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?
Gounaris I; Charnock-Jones DS; Brenton JD
J Pathol; 2011 Oct; 225(2):157-60. PubMed ID: 21898874
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.
Ye S; Zhou S; Wu Y; Pei X; Jiang W; Shi W; Yang W; Zhou X; Shan B; Yang H
Ann Med; 2023 Dec; 55(1):2218104. PubMed ID: 37272300
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing the progression of an endometrioma: Benign or malignant?
Bastu E; Onder S; Demiral I; Ozsurmeli M; Keskin G; Takmaz O; Ozaltin S; Gorgen H; Gungor M; Yavuz E; Buyru F
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():79-84. PubMed ID: 30245441
[TBL] [Abstract][Full Text] [Related]
11. Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases.
Zannoni GF; Santoro A; Angelico G; Spadola S; Arciuolo D; Valente M; Inzani F; Pettinato A; Vatrano S; Fanfani F; Scambia G; Fraggetta F
Hum Pathol; 2019 Oct; 92():10-17. PubMed ID: 31269413
[TBL] [Abstract][Full Text] [Related]
12. [Study on expression of estrogen receptor isoforms in eutopic and ectopic endometrium of ovarian endometriosis].
Liu AJ; Guan Z; Zhang ZM; Wei LX; Li YL
Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):584-8. PubMed ID: 19094579
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology.
Guo SW
Hum Reprod Update; 2020 Apr; 26(3):423-449. PubMed ID: 32154564
[TBL] [Abstract][Full Text] [Related]
14. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
[TBL] [Abstract][Full Text] [Related]
15. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
Kuo KT; Mao TL; Jones S; Veras E; Ayhan A; Wang TL; Glas R; Slamon D; Velculescu VE; Kuman RJ; Shih IeM
Am J Pathol; 2009 May; 174(5):1597-601. PubMed ID: 19349352
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic mutations in histologically normal endometrium: the new normal?
Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract][Full Text] [Related]
19. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930
[TBL] [Abstract][Full Text] [Related]
20. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma.
Su YF; Tsai EM; Chen CC; Wu CC; Er TK
Clin Chim Acta; 2019 Jul; 494():1-7. PubMed ID: 30851247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]